There are few more frustrating things in life than being ready for sleep, yet unable to catch the ‘zzzzz’s’ you need. Before you know it, your mind starts dissecting trivialities, like whether you have enough fairy cakes for Canada Day, when it really should be shutting down for a few precious hours of reenergizing.
ResMed’s experience in the field of sleep deprivation has enabled it to provide the most effective sleep medicine and non-invasive ventilation systems for people with respiratory disorders, who find it difficult to switch off when their head hits the pillow. Since it began in 1989, the company has advanced the diagnosis, treatment and long-term management of sleep-disordered breathing, while its techniques and products are the result of life-changing and innovative technological advances in the industry.
Problematic sleeping is a problem that unites the world and therefore ResMed offers its comprehensive range of products across more than 70 countries, through direct offices and a network of distributors.
Snoring and sleep apnea are common sleep-disordered breathing (SDB) problems that can affect your sleep, health and quality of life. According to research, about one in every five adults has SDB and, let’s face it, we all know at least one person with a propensity for thunderous snoring (and if you don’t, it’s probably you).
In some cases snoring and sleep apnea occur together, causing the airway to narrow, limiting airflow as you breathe or triggering vibrations (a catalyst for the irritating noise that characterizes snoring). The airway may also collapse, causing the individual to stop breathing momentarily.
One of the most popular treatments for customers is the device for addressing obstructive sleep apnea (OSA). ResMed use the groundbreaking ‘continuous positive airway pressure’ (CPAP) devised by Professor Colin Sullivan. The procedure was developed in the early 1980s and represented the very first non-invasive remedy for OSA. ResMed made it available internationally as the public became more informed about problems relating to sleep. Treatment involves wearing a mask, or nasal pillows system, connected to a small portable airflow generator that delivers air at positive pressure. This pressure acts like an ‘air splint’ to keep the passage open. When patients are able to get back into a regular sleep pattern they often report that their overall health improves—dramatically in some cases.
Another option, Automatic Positive Airway Pressure (APAP), is a therapy that automatically varies the pressure throughout the night, actively responding to the continuous changes in the upper airway. It is the most sophisticated system in the range and makes necessary adjustments on a breath by breath basis—blowing the minimum pressure needed to keep the airway open during sleep. This allows the machine to provide patients with the ideal pressure for the entire night.
Some of the APAP devices have incorporated ResMed’s groundbreaking AutoSet technology. Most of the respiratory devices only adjust pressure after apnea, hypopnea or snoring has occurred, but AutoSet devices actually concentrate on prevention. They respond pre-emptively to apneas and hypopneas by monitoring the user’s inspiratory flow-time curve. Changes in this curve indicate the likely occurrence of unwanted activity and tackle the problem before it manifests. Some apneas will occur without any physical warning, and in these situations, the AutoSet device responds to the severity of the apnea, by not providing too much or little additional pressure.
Clinical trials have found that our AutoSet devices prevent more apneas and hypopneas while operating at lower average pressures than fixed devices.
The third option is bilevel therapy which works by delivering two different levels of positive air pressure—higher when breathing in and lower on the outtake of breath. This system provides non-invasive positive pressure ventilation (NPPV) for people with respiratory disorders other than OSA, including nocturnal hypoventilation, respiratory insufficiency, neuromuscular disease, respiratory failure and chest wall deformity. It is particularly useful if patients found CPAP therapy too difficult, require higher treatment pressure or have another respiratory condition.
In order to support future advances and demonstrate its commitment to medicine and practices, the company continually invests six per cent of revenues in research and product development.
With that sort of devotion we can all get a good night’s sleep.